Sign In
Buy CATX
$3.56
-0.0400 (-1.11%)
At Close: Jun 03, 2026
Perspective Therapeutics to Participate at Upcoming Investor Conferences in August
07:00am, Tuesday, 30'th Jul 2024
SEATTLE, July 30, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced t
3 Outperforming Stocks Surpassing Even Nvidia This Year
06:15am, Thursday, 25'th Jul 2024
Nvidia (NASDAQ: NVDA ) is having a fantastic year in the markets, up 156% in 2024. That follows a 2023 return of 239%.
Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2024 Financial Results
07:00am, Monday, 22'nd Jul 2024
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout
Wall Street Analysts Think Perspective Therapeutics (CATX) Could Surge 80.31%: Read This Before Placing a Bet
10:56am, Tuesday, 16'th Jul 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 80.3% in Perspective Therapeutics (CATX). While the effectiveness of this highly sought-after metric is questio
Perspective Therapeutics Announces Inclusion in the Russell 3000® Index
07:00am, Wednesday, 12'th Jun 2024
SEATTLE, June 12, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced tre
Perspective Therapeutics Announces 1-for-10 Reverse Stock Split
07:00am, Tuesday, 11'th Jun 2024
SEATTLE, June 11, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced trea
Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
04:10pm, Monday, 10'th Jun 2024
SEATTLE, June 10, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced tr
Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
08:01am, Friday, 24'th May 2024
SEATTLE, May 24, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treat
Insider Trading is Good News for These Stocks
09:45am, Monday, 20'th May 2024
Insiders are buying these hot stocks that have ample upside for investors. The list includes pharma, entertainment, and financial stocks and Berkshire buys.
Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024
07:00am, Monday, 20'th May 2024
SEATTLE, May 20, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced trea
CATX Stock Earnings: Perspective Therapeutics Meets EPS for Q1 2024
11:54am, Wednesday, 15'th May 2024
Perspective Therapeutics (NYSEMKT: CATX ) just reported results for the first quarter of 2024. Perspective Therapeutics reported earnings per share of -2 cents.
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
07:00am, Wednesday, 15'th May 2024
SEATTLE, May 15, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treat
Perspective Therapeutics to Participate at Upcoming May Investor Conferences
07:00am, Friday, 03'rd May 2024
SEATTLE, May 03, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced tr
Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financial Results
07:00am, Thursday, 02'nd May 2024
SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout
SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throug
